Amgen Defends Patent For Thyroid Disease Drug At EPO
A European appeals panel has upheld Amgen's patent for a thyroid disease treatment following a challenge from generic-drug maker Stada, ruling in a decision released Monday that the patent is inventive....To view the full article, register now.
Already a subscriber? Click here to view full article